Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis.
Tao JiangMeng QiaoChao ZhaoXuefei LiGuanghui GaoChunxia SuShengxiang RenCaicun ZhouPublished in: Cancer immunology, immunotherapy : CII (2018)
Elevated pretreatment blood NLR was a promising prognostic and predictive biomarker for advanced-stage cancer patients treated with immunotherapy.